Long‐term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM‐3 study

• Michael H. Tomasson,
• Shinsuke Iida,
• Ruben Niesvizky,
• Mohamad Mohty,
• Nizar J. Bahlis,
• Joaquin Martinez‐Lopez,
• Guenther Koehne,
• Paula Rodriguez‐Otero,
• H. Miles Prince,
• Andrea Viqueira,
• Eric Leip,
• Umberto Conte,
• Sharon T. Sullivan,
• Alexander M. Lesokhin

Affiliations

Michael H. Tomasson

Department of Internal Medicine University of Iowa Iowa City Iowa USA

Shinsuke Iida

Department of Hematology & Oncology Nagoya City University Graduate School of Medical Sciences Nagoya Japan

Ruben Niesvizky

Multiple Myeloma Center New York–Presbyterian Hospital/Weill Cornell Medical Center New York New York USA

Mohamad Mohty

Hematology and Cellular Therapy Department Sorbonne University, Hôpital Saint‐Antoine and INSERM UMRS938 Paris France

Nizar J. Bahlis

Division of Hematology and Bone Marrow Transplantation, Arnie Charbonneau Cancer Institute University of Calgary Calgary Alberta Canada

Joaquin Martinez‐Lopez

Haematology and Haemotherapy Service Hospital Universitario 12 de Octubre, Complutense University of Madrid, Centro Nacional de Investigaciones Oncológicas, Instituto de Investigación Hospital 12 de Octubre Madrid Spain

Guenther Koehne

Blood & Marrow Transplant and Hematologic Oncology Miami Cancer Institute Miami Florida USA

Paula Rodriguez‐Otero

Central Unit for Clinical Trials Clinica Universidad de Navarra Madrid Spain

H. Miles Prince

Cancer Immunology and Molecular Oncology Epworth Healthcare and University of Melbourne Melbourne Victoria Australia

Andrea Viqueira

Oncology Research and Development Pfizer SLU Madrid Spain

Eric Leip

Department of Clinical Research Pfizer Inc. Cambridge Massachusetts USA

Umberto Conte

Oncology Research and Development Pfizer Inc. New York New York USA

Sharon T. Sullivan

Global Product Development Pfizer Inc. Cambridge Massachusetts USA

Alexander M. Lesokhin

Division of Hematology and Oncology Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College New York New York USA